These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 84774)

  • 1. [Dysfunctional uterine bleeding. Hormonal management with chlormadinone acetate].
    Olivas Mendoza G; Santos Martínez A; Corral Olaguez M; Iduñate y Carlos DM; Hernández Ayup S
    Ginecol Obstet Mex; 1978 Dec; 44(266):463-71. PubMed ID: 84774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Estrogen-gestagen therapy with hormonally induced uterine bleeding. II. Therapeutic use of Klimovan].
    Cséffalvay T; Klose S
    Dtsch Gesundheitsw; 1965 Jul; 20(29):1334-9. PubMed ID: 5319408
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of treatment of patients with dysfunctional uterine hemorrhages with different types of synthetic progestins].
    Sotnikova EI
    Sov Med; 1975 Jun; (6):31-5. PubMed ID: 1162470
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of intravenous Premarin in the treatment of dysfunctional uterine bleeding--a double-blind randomized control study.
    DeVore GR; Owens O; Kase N
    Obstet Gynecol; 1982 Mar; 59(3):285-91. PubMed ID: 6281704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chlormadinone therapy of menstruation disorders].
    Stanev S; Trepechov S
    Akush Ginekol (Sofiia); 1973; 12(2):110-5. PubMed ID: 4128262
    [No Abstract]   [Full Text] [Related]  

  • 6. [Advantage of the use of an estroprogestational drug: 3 mg of chlormadinone acetate + 100 mcg of mestranol in endocrine gynecology].
    Bernard I
    Bord Med; 1970; 3(7):1954-60. PubMed ID: 4195405
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the behavior of the hemostatic system during hormonal treatment of menstruation disorders].
    Musiatowicz J; Bielecki M; Jezuita J; Wielkopolan J
    Wiad Lek; 1968 Jul; 21(13):1119-23. PubMed ID: 5670518
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of synthetic steroid preparations for hemostasis and normalization of menstrual function in juvenile hemorrhages].
    Kuznetsova MN; Antipina NN; Zagorskaia EA
    Vopr Okhr Materin Det; 1978 Feb; 23(2):77-80. PubMed ID: 347706
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lutenyl and menstrual disorders. A hospital study].
    Cohen A; Engelmann P; Erny R; Favier M; Ghéron G
    Rev Fr Gynecol Obstet; 1988 Nov; 83(11):741-3. PubMed ID: 3206099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sequential treatment in menstrual irregularities and ovulation disorders].
    Bernard I
    Bull Fed Soc Gynecol Obstet Lang Fr; 1966; 18(3):255-7. PubMed ID: 4164207
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of menopause disorders by the sequential method].
    Gaudefroy M
    J Sci Med Lille; 1970 Dec; 88(12):637-49. PubMed ID: 4100661
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of the system of progesterone liberation in uterol in dysfunctional uterine bleeding].
    Ruiz Velasco V; Martínez Manautou J; Illanes Amurrio S; Maqueo Topete M; Conde de Vargas BI
    Ginecol Obstet Mex; 1974 Aug; 36(214):115-27. PubMed ID: 4430447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunctional uterine bleeding.
    Smith SK
    Br J Hosp Med; 1985 Dec; 34(6):351-4. PubMed ID: 4084703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the effectiveness of a new gestagen in the treatment of bleeding anomalies. A clinical contribution to the problem of oral gestagen therapie].
    Thewanger W
    Wien Klin Wochenschr; 1965 Jun; 77(25):468-9. PubMed ID: 5319349
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy.
    Bourdrez P; Bongers MY; Mol BW
    Fertil Steril; 2004 Jul; 82(1):160-6, quiz 265. PubMed ID: 15237006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative cytological and histological studies following the use of an ovulation inhibiting estrogen-gestagen combination (Ovositon)].
    Krause W; Böhm W; Müller W
    Gynaecologia; 1968; 166(5):432-45. PubMed ID: 4179218
    [No Abstract]   [Full Text] [Related]  

  • 17. [Norethisterone acetate in the therapy of functional hemorrhages of the endometrium].
    Montemagno U
    Arch Ostet Ginecol; 1968; 73(4):421-40. PubMed ID: 5718494
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experiences with a gestagen-estrogen preparation (AK 103=Aconcen)].
    Kalchauer B
    Ther Ggw; 1966 Jul; 105(7):938-9. PubMed ID: 4162578
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of dysfunctional uterine hemorrhage with 6-chloro-6-dehydro-17-alpha-acetoxyprogesterone].
    CASARES PONCE HJ
    Medicina (Mex); 1963 Mar; 43():136-40. PubMed ID: 14019046
    [No Abstract]   [Full Text] [Related]  

  • 20. Abnormal uterine bleeding.
    Connell A
    Nurse Pract; 1989 Apr; 14(4):40, 43-4, 47 passim. PubMed ID: 2652003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.